Category: Patient Resources

Foundayo: The New GLP-1 Pill

Foundayo (orforglipron) is the first oral GLP-1 medication approved for weight loss — but the clinical trial data reveals a meaningful efficacy gap compared to current injectable options. I break down the ATTAIN-1 trial results, the liver metabolism factor most reviews miss, and my practical framework for deciding whether to start or switch.

BPC‑157 & TB‑500 vs Ozempic: The Truth About “Healing Peptides”

Healing peptides like BPC-157 and TB-500 are being marketed as the cutting-edge, natural alternative to GLP-1 medications — but the clinical reality tells a very different story. I break down the Buy-In Effect, the real safety risks of unregulated peptides, and four evidence-based steps that actually protect your progress.

GLP-1 Side Effects: Why You’re Sick (And How to Fix It)

GI side effects on Wegovy or Zepbound are not proof the medication is working — they’re a signal your protocol needs adjusting. My 6-step GI Stability Protocol will give you a concrete, pharmacist-backed framework to manage nausea and stop the guesswork.

Ozempic Personality – Your Brain On GLP-1s

You did the hard work, the medication is working, the scale is moving — but somewhere along the way, your joy went quiet. The science behind emotional flattening on GLP-1 medications is real, it’s validated, and most importantly, it’s fixable.

The Sleep Mistake Blunting Your GLP-1 Results

You’re doing everything right—but your 6 AM alarm might be quietly sabotaging your results, blunting your GLP-1 and driving cravings you think are “your fault.” Miss those last 2 hours of sleep, and you could be leaving up to 20% of your fat loss on the table—while your brain fights you every step of the way.

Are GLP-1s Destroying Your Bones?

Worried that Ozempic or other GLP-1 medications cause osteoporosis? I’m breaking down the real science behind bone density changes during rapid weight loss, AND sharing a proven step-by-step strategy to protect your bones while continuing to lose weight safely.

Ozempic + Bimagrumab: The Drug Combo That Could Change Weight Loss Forever

A new Phase 2 trial in Nature Medicine tested semaglutide with a myostatin blocker called bimagrumab. The result: over 90% fat loss, minimal muscle loss, and a glimpse into the future of body composition medicine.

Did CagriSema Really Fail Against Tirzepatide?

The headlines say a major obesity treatment “failed,” but the trial still produced about 20% body weight loss. A closer look at the data reveals why the real story is far more encouraging than the media suggests.

The Ozempic Plateau Explained

Hitting a weight loss plateau on Ozempic or Mounjaro? I’m explaining why it’s not the medication failing — it’s your body’s survival system — and I’ve got 5 science-backed steps to get the scale moving again.

Stopping Zepbound – A SURMOUNT-4 Analysis

The SURMOUNT-4 trial showed that most people regained a significant portion of their lost weight after stopping treatment — even with lifestyle support. Learn what this means for long-term success and how to plan a smarter maintenance strategy.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.